In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...

A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...

(Colorado Newsline) Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap the price of a prescription drug used to treat rheumatoid ...

Abbott Laboratories, a maker of drugs and other health care products, said yesterday that it has submitted its rheumatoid arthritis drug to regulators in the United States and Europe for approval. The ...

Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...

Last year, the board voted to deem Enbrel “unaffordable,” setting up a months-long process of determining whether it should ...

Amgen said Friday it applied for clearance to begin using a manufacturing plant in Rhode Island to make rheumatoid arthritis treatment Enbrel. There has been a continuing problem with insufficient ...

NEW YORK, Jan 17 (Reuters) - New Jersey's attorney general said on Thursday she has subpoenaed Amgen Inc regarding allegations that the biotechnology company promoted its rheumatoid arthritis and ...

“A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998,” according to the allegations in the antitrust class action filed against Enbrel ...